Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days
Status:
COMPLETED
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the safety and tolerability after single and repeated twice daily intra-anal applications of 1mL NRL001 cream in stepwise increasing concentrations.